SMITHBRIDGE ASSET MANAGEMENT INC/DE

Position in LLY — ELI LILLY & Co

CIK 1103245 Chadds Ford, PA

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$7,056,247

+$1,391,384 QoQ

Shares Held

5,883

-4.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.40%

of 13F equity value

Holder Rank

#1,467

of 4,605 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

SMITHBRIDGE ASSET MANAGEMENT INC/DE holds $39,618,201 across 7 Drug Manufacturers - General names. LLY ranks #4 (17.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	43,597	$11,072,330
2	NVS	Novartis AG	49,133	$7,700,123
3	ABBV	AbbVie Inc.	29,215	$7,351,662
4	LLY	ELI LILLY & Co This page	5,883	$7,056,247
5	NVO	Novo Nordisk A S	102,069	$4,893,187
6	MRK	Merck & Co., Inc.	10,048	$1,291,168
7	AMGN	Amgen Inc	700	$253,484

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,056,247	5,883	-4.5%	Shares	Sole	2026-07-20
2026-03-31	$5,664,863	6,159	-51.2%	Shares	Sole	2026-04-24
2025-12-31	$13,563,537	12,621	+1.2%	Shares	Sole	2026-02-11
2025-09-30	$9,518,425	12,475	-2.4%	Shares	Sole	2025-10-29
2025-06-30	$9,967,850	12,787	-4.9%	Shares	Sole	2025-07-29
2025-03-31	$11,110,141	13,452	-6.0%	Shares	Sole	2025-04-16
2024-09-30	$12,672,485	14,304	+75.3%	Shares	Sole	2024-10-24
2024-06-30	$7,388,806	8,161	-15.1%	Shares	Sole	2024-07-19
2024-03-31	$7,480,863	9,616	-5.1%	Shares	Sole	2024-05-03
2023-12-31	$5,907,894	10,135	-1.4%	Shares	Sole	2024-01-18
2023-09-30	$5,521,159	10,279	-6.3%	Shares	Sole	2023-10-25
2023-06-30	$5,142,834	10,966	-1.0%	Shares	Sole	2023-07-20
2023-03-31	$3,804,750	11,079	+0.7%	Shares	Sole	2023-04-20
2022-12-31	$4,023,508	10,998	—	Shares	Sole	2023-03-01
No filing history on record for this holder in this stock.